INTU and invasive carcinoma: On the other hand, disease progression—leading to invasive carcinoma and subsequent metastatic spread—is likely driven by specific molecular pathways (Wnt/β‐catenin, FgF, Notch, and others), which are, in turn, activated by Int genes.7